Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Reported Basic Consolidated EPS Of $0.6239 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) for the period ended 2015-12-31 was $0.6239. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $0.6239.

EPS from continuing operations

Coming to basic EPS from continuing operations, Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) reported $0.6239 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $0.6239.

EPS contribution from parent

For the annual period ended 2015-12-31, Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) received basic EPS of $0.6239 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $0.6239.

Basic net EPS

For the annual period ended 2015-12-31, Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) reported basic net EPS of $0.62. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $0.62.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $0.5964. For the quarter ended 2015-12-31, consolidated diluted EPS was $0.5964.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $0.5964 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $0.5964.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $0.54. For the quarterly period ended 2015-12-31, net diluted EPS was $0.54.

Diluted EPS from parent

From the parent company, Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) received diluted EPS of $0.5964 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $0.5964.

Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) posted net basic EPS reading of $0.62 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $0.62 was for the quarter ended 2015-12-31.

Net diluted EPS for Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) for the annual period ended 2015-12-31 was $0.54. The company also reported net diluted EPS reading of $0.54 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 70.242 while for the quarter ended 2015-12-31 is 70.242.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 73.483 while for the quarter ended 2015-12-31 is 73.483.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 41 times, 1 visits today)